• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed Mutant Non-Small-Cell Lung Cancer.

作者信息

Mooradian Meghan J, Piotrowska Zofia, Drapkin Benjamin J, Dias-Santagata Dora, Marcoux Nicolas, Arnaoutakis Konstantinos, Nagy Rebecca J, Lanman Richard, Iafrate Anthony J, Farago Anna F, Mino-Kenudson Mari, Hata Aaron N, Sequist Lecia V

机构信息

Massachusetts General Hospital, Boston, MA.

University of Arkansas for Medical Sciences, Little Rock, AR.

出版信息

JCO Precis Oncol. 2017;1. doi: 10.1200/PO.17.00123. Epub 2017 Nov 7.

DOI:10.1200/PO.17.00123
PMID:31032471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6483387/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/26b94e6661f4/nihms-992577-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/20f59114a40e/nihms-992577-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/4aaf030ee042/nihms-992577-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/0e5d5fdf4615/nihms-992577-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/5ca7dbf2783f/nihms-992577-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/26b94e6661f4/nihms-992577-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/20f59114a40e/nihms-992577-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/4aaf030ee042/nihms-992577-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/0e5d5fdf4615/nihms-992577-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/5ca7dbf2783f/nihms-992577-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54e/6483387/26b94e6661f4/nihms-992577-f0005.jpg

相似文献

1
Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed Mutant Non-Small-Cell Lung Cancer.克隆进化以及系列液体活检在一例小细胞肺癌转化为突变型非小细胞肺癌病例中的作用
JCO Precis Oncol. 2017;1. doi: 10.1200/PO.17.00123. Epub 2017 Nov 7.
2
Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancer.通过肺癌中异质突变型表皮生长因子受体基因的循环肿瘤DNA监测肿瘤细胞的治疗反应和克隆进化
Lung Cancer. 2016 Apr;94:68-73. doi: 10.1016/j.lungcan.2016.01.023. Epub 2016 Feb 2.
3
EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer.EGFR阳性非小细胞肺癌转化为小细胞肺癌化疗后出现EGFR T790M突变。
Respir Med Case Rep. 2018 Mar 16;24:19-21. doi: 10.1016/j.rmcr.2018.03.009. eCollection 2018.
4
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.肺腺癌演变为小细胞癌的克隆进化史和遗传预测因子。
J Clin Oncol. 2017 Sep 10;35(26):3065-3074. doi: 10.1200/JCO.2016.71.9096. Epub 2017 May 12.
5
Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma.配对基因组分析 EGFR 突变型肺腺癌转化的鳞状细胞癌。
Lung Cancer. 2019 Aug;134:7-15. doi: 10.1016/j.lungcan.2019.05.024. Epub 2019 May 24.
6
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.克隆性 MET 扩增作为表皮生长因子受体突变型非小细胞肺癌酪氨酸激酶抑制剂耐药的决定因素。
J Clin Oncol. 2019 Apr 10;37(11):876-884. doi: 10.1200/JCO.18.00177. Epub 2019 Jan 24.
7
Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer.一名表皮生长因子受体（EGFR）突变的非小细胞肺癌腺癌亚型转化为小细胞肺癌的患者对纳武单抗无反应。
Lung Cancer. 2017 Sep;111:65-68. doi: 10.1016/j.lungcan.2017.07.012. Epub 2017 Jul 11.
8
Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies.非小细胞肺癌中表皮生长因子受体靶向治疗获得性耐药：机制与治疗策略。
Cancer Treat Rev. 2018 Apr;65:1-10. doi: 10.1016/j.ctrv.2018.02.006. Epub 2018 Feb 20.
9
Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencing.表皮生长因子受体突变阳性非小细胞肺癌中的肿瘤克隆性和耐药机制：对治疗顺序的影响。
Future Oncol. 2019 Feb;15(6):637-652. doi: 10.2217/fon-2018-0736. Epub 2018 Nov 8.
10
Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures.表皮生长因子受体突变型非小细胞肺癌（NSCLC）的治疗：成功之路，铺满失败。
Pharmacol Ther. 2017 Jun;174:1-21. doi: 10.1016/j.pharmthera.2017.02.001. Epub 2017 Feb 4.

引用本文的文献

1
Liquid biopsy in diagnosis and monitoring of treatment efficacy in patients with small cell lung cancer.液体活检在小细胞肺癌患者诊断及治疗疗效监测中的应用
Mol Biol Rep. 2025 May 13;52(1):455. doi: 10.1007/s11033-025-10569-1.
2
Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs.小细胞肺癌中外源 DNA 扩增导致 MYC 基因家族的获得性交叉耐药。
Cancer Discov. 2024 May 1;14(5):804-827. doi: 10.1158/2159-8290.CD-23-0656.
3
Neoadjuvant Chemo-Immunotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Review of the Literature.

本文引用的文献

1
Unlocking the Mystery of Small-Cell Lung Cancer Transformations in EGFR Mutant Adenocarcinoma.揭开EGFR突变腺癌中小细胞肺癌转化之谜
J Clin Oncol. 2017 Sep 10;35(26):2987-2988. doi: 10.1200/JCO.2017.73.5696. Epub 2017 Jul 10.
2
Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.血液衍生循环肿瘤 DNA（ctDNA）的基因组评估在晚期肺腺癌患者中的效用。
Clin Cancer Res. 2017 Sep 1;23(17):5101-5111. doi: 10.1158/1078-0432.CCR-16-2497. Epub 2017 May 24.
3
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.
局部晚期非小细胞肺癌的新辅助化疗免疫治疗：文献综述
J Clin Med. 2022 May 7;11(9):2629. doi: 10.3390/jcm11092629.
4
Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma.小细胞肺癌转化的表皮生长因子受体突变肺腺癌的治疗模式和临床结局的综合分析。
Thorac Cancer. 2021 Oct;12(19):2585-2593. doi: 10.1111/1759-7714.14144. Epub 2021 Sep 6.
5
Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis.用于新发或转化型小细胞肺癌的液体活检：不同应用的系统评价和荟萃分析
Cancers (Basel). 2021 May 8;13(9):2265. doi: 10.3390/cancers13092265.
6
[Mechanism of Histologic Transformation of Drive Gene Positive Lung Adenocarcinoma in Targeted Therapy and Treatment Strategy].[驱动基因阳性肺腺癌在靶向治疗中的组织学转化机制及治疗策略]
Zhongguo Fei Ai Za Zhi. 2020 Aug 20;23(8):701-709. doi: 10.3779/j.issn.1009-3419.2020.102.22. Epub 2020 Aug 6.
7
Tumor evolution in epidermal growth factor receptor mutated non-small cell lung cancer.表皮生长因子受体突变的非小细胞肺癌中的肿瘤演变
J Thorac Dis. 2020 May;12(5):2896-2909. doi: 10.21037/jtd.2019.08.31.
8
Influence of Mutation on Survival in Patients With Advanced -Mutant Non-Small-Cell Lung Cancer.突变对晚期突变型非小细胞肺癌患者生存的影响。
JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00107. Epub 2018 Aug 31.
肺腺癌演变为小细胞癌的克隆进化史和遗传预测因子。
J Clin Oncol. 2017 Sep 10;35(26):3065-3074. doi: 10.1200/JCO.2016.71.9096. Epub 2017 May 12.
4
The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?首个获批的液体活检检测。这会是一个非小细胞肺癌突变检测的新时代吗？
Ann Transl Med. 2017 Feb;5(3):46. doi: 10.21037/atm.2017.01.32.
5
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer.晚期非小细胞肺癌患者血浆基因分型与奥希替尼（AZD9291）治疗结果的相关性
J Clin Oncol. 2016 Oct 1;34(28):3375-82. doi: 10.1200/JCO.2016.66.7162. Epub 2016 Jun 27.
6
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.循环肿瘤 DNA 分析揭示了肺癌患者中 EGFR 抑制剂耐药机制的异质性。
Nat Commun. 2016 Jun 10;7:11815. doi: 10.1038/ncomms11815.
7
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care.循环 DNA 作为转移性结直肠癌患者管理护理的强有力的多标志物预后工具。
Clin Cancer Res. 2016 Jun 15;22(12):3067-77. doi: 10.1158/1078-0432.CCR-15-0297. Epub 2016 Feb 4.
8
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.结直肠癌中的肿瘤异质性及对靶向治疗的病灶特异性反应
Cancer Discov. 2016 Feb;6(2):147-153. doi: 10.1158/2159-8290.CD-15-1283. Epub 2015 Dec 7.
9
Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer.小细胞肺癌转化与T790M突变：在肺癌对激酶抑制剂获得性耐药中的互补作用
Sci Rep. 2015 Sep 24;5:14447. doi: 10.1038/srep14447.
10
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor.异质性是用第三代EGFR抑制剂治疗T790M阳性癌症后出现EGFR T790野生型克隆的基础。
Cancer Discov. 2015 Jul;5(7):713-22. doi: 10.1158/2159-8290.CD-15-0399. Epub 2015 May 1.